Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript December 12, 2023
Champions Oncology, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.17.
Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Ronnie Morris, CEO....
